STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AS A NEW PRECISION TREATMENT OPTION IN KIDNEY CANCER

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

Shankar Siva, Brent Chesson, Mathias Bressel, David Pryor, Braden Higgs, Hayley M Reynolds, Nicholas Hardcastle, Rebecca Montgomery, Ben Vanneste, Vincent Khoo, Jeremy Ruben, Eddie Lau, Michael S Hofman, Richard De Abreu Lourenco, Swetha Sridharan, Nicholas R Brook, Jarad Martin, Nathan Lawrentschuk, Tomas Kron, Farshad Foroudi

2018-10-23

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell ..